Trade State Street SPDR S&P Pharmaceuticals ETF - XPH CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.26
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02226 %(-$1.11)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: -0.02226%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position0.00004 %($0.00)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: 0.00004%
• Overnight funding adjustment time: 22:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02226 %
  (-$1.11)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.00004 %
  ($0.00)

Key Stats

• Prev. Close: 66.82
• Open: 66.23
• 1-Year Change: 30.27%
• Day's Range: 65.66 - 66.93

Trade State Street SPDR S&P Pharmaceuticals ETF - XPH

What is State Street SPDR S&P Pharmaceuticals ETF (XPH)?

State Street SPDR S&P Pharmaceuticals ETF is an exchange-traded fund that seeks to provide investment results corresponding to the performance of the S&P Pharmaceuticals Select Industry Index. The fund primarily invests in companies engaged in the pharmaceutical industry, including those involved in the development, production, and marketing of drugs and related products. Its holdings typically encompass a range of pharmaceutical manufacturers, biotechnology firms, and related entities. The fund offers exposure to the pharmaceutical sector by tracking a diversified portfolio of companies selected based on market capitalization and liquidity criteria. It is designed for investors seeking targeted exposure to the pharmaceutical industry within a broader investment strategy. The fund is managed by State Street Global Advisors, a prominent asset management firm known for its range of exchange-traded funds and index-based investment products. It provides a means for investors to access the pharmaceutical sector through a single investment vehicle that reflects the performance of a defined industry index.

State Street SPDR S&P Pharmaceuticals ETF Stock Price Today: Live Overview

The price today is shaped by trading fluctuations as ProShares Ultra FTSE China 50 trades at $66.99. The price range for the day lies between $65.54 and $66.96, with a daily percentage shift of -0.1048%.

FAQ: State Street SPDR S&P Pharmaceuticals ETF (XPH)

What is the current price of XPH stock?

The current price is $66.99.

Does XPH pay dividends?

State Street SPDR S&P Pharmaceuticals ETF does not pay dividends.

Does XPH have a formal corporate presence or regional headquarters in the UAE?

State Street operates in the UAE via its Dubai International Financial Centre (DIFC) office.

What is XPH best known for?

This ETF is most famous for its focus on pharmaceutical companies within the S&P index.

What assets are typically shown together with XPH?

Commonly shown alongside XPH: LPL Financial Holdings Inc, Willis Towers Watson PLC, LSE